Navigating New Regulatory Landscapes for Drug Delivery

products-servicesURSATEC GmbH

July 9th 2025

As the pharmaceutical and healthcare industries evolve, so do the regulatory frameworks that govern them. In 2025, drug delivery systems – especially those designed for preservative-free formulations – are under increased scrutiny. Global regulatory bodies are placing greater emphasis on patient safety, environmental sustainability, and technological reliability.

The introduction of the MDR (Medical Device Regulation) provides an example of how changes in regulatory guidelines represent a major challenge for many manufacturers in the healthcare industry.

Evolving Regulatory Trends

The regulatory environment in 2025 reflects heightened concerns around:

Patient safety and microbiological integrity: Agencies like the EMA, FDA, and WHO are pushing for reduced use of preservatives due to their known side effects, such as mucosal irritation and long-term tissue damage.
Sustainability emphasis: Environmental regulations are encouraging the use of recyclable materials and sustainable manufacturing practices.
Data-driven product validation: Digital traceability and performance verification are now integral to regulatory approval.

For companies developing nasal sprays, inhalers, eye drops, and other multi-dose systems, these changes present both challenges and opportunities. Preservative-free systems must maintain sterility without preserving agents, often requiring advanced device design and rigorous validation.

URSATEC’s Role in Regulatory Compliance

URSATEC has been at the forefront of preservative-free drug delivery for over three decades and its technologies and consulting services are more relevant than ever. URSATEC helps clients meet emerging regulatory demands in various ways:

1. Proprietary Preservative-Free Systems

URSATEC’s comprehensive portfolio of multi-dose delivery systems, including the 3K® non-airless system and COMFORT airless system®, maintains sterility through mechanical design rather than preserving agents. These systems comply with strict microbiological integrity standards and are ideal for sensitive applications including ophthalmology, dermatology, and pediatrics.

2. Regulatory Expertise and Documentation Support

Clients benefit from URSATEC’s deep understanding of global regulatory requirements when it comes to providing technical documentation aligned with MDR (EU Medical Device Regulation), FDA cGMP guidelines, and ISO standards, along with microbiological challenge testing and validation reports to demonstrate product safety and performance.

3. Sustainable Design and Manufacturing

In alignment with ESG expectations, URSATEC prioritizes sustainability by using recyclable materials where possible and minimizing the environmental footprint of its devices. These practices not only support regulatory compliance but also meet growing consumer and stakeholder demands for eco-conscious healthcare solutions.

4. Collaborative Product Development

URSATEC’s team works closely with clients from concept to market, ensuring that every aspect of the product – from material selection to final validation – meets the latest standards. This partnership approach reduces time to market and increases the likelihood of regulatory approval.

URSATEC as regulatory partner

Amid this dynamic landscape, URSATEC stands out as a trusted partner, helping clients navigate the complex web of compliance through innovation and expertise in preservative-free delivery technologies.

Dealing with complex regulatory issues is part of URSATEC’s daily business. The company is a market leader in preservative-free technologies and related regulatory issues and its ONE SOURCE® one-stop-shop offer is designed to ensure that new products can quickly come to market.

URSATEC has ISO 13485, ISO 9001 and ISO 15378 certifications and can handle the communications with authorities required to obtain registration in the respective markets. It can also take on responsibility for preparing required technical documentation.

With stricter global standards and rising demand for patient-friendly, preservative-free treatments, pharmaceutical companies must adapt swiftly. URSATEC offers the technology, knowledge, and support needed to succeed in this highly dynamic regulatory era.